Searched for
GSK VIR THERAPY
GSK-Vir therapy works against Omicron sub-variant, data suggestsBased on pseudovirus and extensive pharmacokinetic data, the company said it believed the 500 mg dose of sotrovimab is sufficient to retain...- Fading Omicron threat, dovish RBI bolster D-Street bullsAll sectors saw buying throughout the day. Banking names continued their rally, while metals also maintained the momentum. Media and realty...
- Wall Street closes higher with Nasdaq boosted by tech rallyThe Dow Jones Industrial Average rose 492.4 points, or 1.4%, to 35,719.43, the S&P 500 gained 95.08 points, or 2.07%, to 4,686.75 and the N...
- Asian shares catch global equities rally, but oil slipsAsian shares extended gains on Wednesday, continuing a global relief rally as markets found positive news in early reports about the potent...
- Oil edge lower as investors try to assess Omicron's full impactBrent crude futures dropped 25 cents, or 0.3%, to $75.19 a barrel at 0129 GMT, after settling 3.2% higher on Tuesday. U.S. West Texas Inter...
- Aussie buoyant, dollar listless as Omicron optimism lifts risk assetsThe Australian dollar hit its strongest level in a week on Wednesday amid a pick-up in risk appetite on signs Omicron may be less severe th...
- Omicron more transmissible than Delta: UK PM Boris Johnson to ministersJohnson's official Number 10 Downing Street spokesperson told reporters in an account of the Cabinet meeting that Johnson reiterated it was...
- New data shows GSK-Vir drug works against all Omicron mutationsThe data, yet to be published in a peer-reviewed medical journal, shows that the companies' treatment, sotrovimab, is effective against all...
- GSK says antibody drug 'Sotrovimab' works against OmicronUK's Medicines and Healthcare products Regulatory Agency has approved sotrovimab, a Covid-19 treatment which has been developed by GSK and ...
- GSK, Vir Biotech to expand COVID-19 research partnership for other diseasesAs a part of the deal to research and develop monoclonal antibody treatments for influenza and other respiratory illnesses, GSK will make a...
Load More
